Dose-Finding Trials: Optimizing Phase 2 Data in the Drug Development Process with Dr Kert Viele
Release Date:
Ed Livingston, MD, FACS, AGAF, discusses Dose-Finding Trials: Optimizing Phase 2 Data in the Drug Development Process with Kert Viele, PhD
Dose-Finding Trials: Optimizing Phase 2 Data in the Drug Development Process with Dr Kert Viele